Cynthia Sears, M.D., FIDSA, Bloomberg~Kimmel Professor of Cancer Immunotherapy, was named next Editor-in-Chief of the Journal of Infectious Diseases. Dr. Sears leads the microbiome program at the Bloomberg~Kimmel Institute for Cancer Immunotherapy, studying how the “bugs” we live with contribute to cancer development and impact the immune response to cancer. Read the full announcement from […]
Read the latest issue of Breast Matters, including how we are using integrative medicine to help patients, immunotherapy news, women's wellness, and healthy aging, the latest research, and more. Click Here To Read Breast Matters!
Introducing Colorectal Cancer Matters, the inaugural issue of the news magazine of the Colorectal Cancer Center of Excellence. CLICK HERE TO READ!
cpetty7 ⋅ Giving Back, Issues & Perspectives, precision medicine, Prevention/Screening, treatment Baltimore Orioles, colorectal cancer, Johns Hopkins Kimmel Cancer Center, Nilofer Azad, Trey Mancini ⋅ No Comments
Don’t miss our latest issue of Promise & Progress: Kimmel in the Community, Working Together for the Citizens of Maryland. CLICK HERE TO READ THE LATEST ISSUE!
Next Friday, November 12 at 11:30 AM EST, Johns Hopkins Kimmel Cancer Center experts are hosting a roundtable discussion on the emerging trends in lung cancer. To participate in this event on Zoom, register for free here.
cpetty7 ⋅ Issues & Perspectives, precision medicine, Research, Survivorship, treatment Christine Argento, Johns Hopkins Kimmel Cancer Center, Joy Feliciano, lung cancer, Rich Battafarano, Russell Hales ⋅ No Comments
Liver cancer is one of the fastest-growing causes of cancer death in the U.S. and in many other parts of the world, says Mark Yarchoan, co-director of the Liver Cancer Multidisciplinary Clinic. Since the new liver cancer clinic launched a little more than a year ago, they have seen a more than 500% increase in […]
cpetty7 ⋅ precision medicine, treatment Bloomberg~Kimmel Institute For Cancer Immunotherapy, Johns Hopkins Kimmel Cancer Center, Liver Cancer, Marina Baretti, MEK Inhibitor, Nilofer Azad ⋅ No Comments
Arnold’s advanced pancreas cancer that had spread to his liver was eliminated with a low-dose, five-drug combination being studied in a clinical trial led by Dung Le. Le is now testing new iterations of the therapy to see if she can help more patients. A new drug cocktail adds immunotherapy and a PARP inhibitor to […]
cpetty7 ⋅ precision medicine, Research, treatment Bloomberg~Kimmel Institute For Cancer Immunotherapy, Dung Le, immunotherapy, Johns Hopkins Kimmel Cancer Center, Karim Boudadi, Lustgarten Foundation, Michael Pishvaian, Nilofer Azad, PARP, Swim Across America ⋅ No Comments
In a research study published online June 24 in the journal Clinical Neurology and Neurosurgery, the research team found that routine radiation treatment after surgery for a rare and slow-growing type of brain tumor called pleomorphic xanthoastrocytoma, or PXAs, was associated with markedly worse overall survival. The researchers reviewed 550 PXA patients from the National […]
Clinton ⋅ Research, treatment Bayview Medical Center, Brain Tumor, Clinical Neurology and Neurosurgery, Johns Hopkins Kimmel Cancer Center, pleomorphic xanthoastrocytoma, PXA, Raj Mukherjee ⋅ No Comments
Researchers at the Johns Hopkins Kimmel Cancer Center are studying the immune system to find what does and doesn't work to better fight soft tissue & bone cancer. “The basis of successful immunotherapy lies in the ability of the immune system to recognize cancer as foreign and attack, and is dependent on genetics, host and […]
Each year, the American Cancer Society publishes data that gives a review of cancer statistics with foundational data that tells us about new cases in the U.S. and details on incidence and survival statistics state by state, overall and by cancer type. The latest report, which made headlines for a historic drop in cancer deaths, […]
Clinton ⋅ Issues & Perspectives, precision medicine, Prevention/Screening, Research, Survivorship, treatment American Cancer Society, Bloomberg~Kimmel Institute For Cancer Immunotherapy, Cancer Matters, Combination Therapy, Johns Hopkins Kimmel Cancer Center, lung cancer, Russell Hales, screening ⋅ No Comments